SAN DIEGO (BUSINESS WIRE) #biotechnews Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, today reported its three and nine months ended September 30, 2023 fin.
Revelation Biosciences, Inc Announces Financial Results for the Three and Nine Months Ended September 30, 2023 lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
NEWPORT BEACH, Calif., Oct. 09, 2023 (GLOBE NEWSWIRE) via InvestorWire / - ROTH MKM (ROTH), www.roth.com, a full-service investment bank focused on serving growth companies and their investors, today
The minutes of the US Federal Reserve’s FOMC meeting held in September will be released on Oct 11 and the consumer price index data for September is due on Oct 12
/PRNewswire/ CervoMed Inc. (NASDAQ: CRVO), a clinical-stage company focused on developing treatments for degenerative diseases of the brain, today announced.